R01DK103363 and R01DK115986), the Cancer Prevention Research Institute of Texas (CPRIT
Founded in 2022, the platform combines affordable compounded medications w
Injectables In a seminal March 2021 New England Journal of Medicine study, adults receiving a weekly 2.4 mg injection of semaglutide for about 15 months lost 15% of their body weight 35 pounds, on average
It is FDA approved to improve blood sugar control in people with Type 2 diabetes
CJC-1295/Ipamorelin is a self-injectable peptide that stimulates the release of growth hormone (GH), which is essential for muscle growth, metabolic function, and healing and recovery
Meta-analysis of results reported from SURPASS-1 to -5 clinical trials regarding reductions in HbA 1c , fasting plasma glucose concentrations, and body weight reductions (all vs